JOSEPH SPEICHER: Open Payments
NPI 1528049822 · MONTROSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 19 payments from 10 companies in 2025. Trend: 2023 $152 · 2024 $219 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
| PFIZER INC. | 3 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $18 |
| Amgen Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: CAMZYOS, Ozempic, REXULTI, Kerendia, PREVNAR 20, ULTOMIRIS, ELIQUIS, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
